Clinical Trials

NCT07654426 | RECRUITING | PHASE2
60 participants

The CARDIOPROTECT Trial

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-27
Start Date:
2026-08-31
Completion:
2030-12-31
Conditions
  • Diffuse Large B-cell Lymphoma (DLBCL)
  • Cardiotoxicity
  • Lymphoma
Interventions
  • DRUG
No Results Yet
NCT07633509 | NOT_YET_RECRUITING | NA
430 participants

The COMBINE-AF Trial

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-27
Start Date:
2026-07-27
Completion:
2028-12-31
Conditions
  • Atrial Fibrillation (AF)
  • Atrial Fibrillation Catheter Ablation
Interventions
  • PROCEDURE
  • DRUG
No Results Yet
NCT07630168 | NOT_YET_RECRUITING | PHASE2
238 participants

Effects of Infusion Timing on Treatment Response in Solid Tumors

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-27
Start Date:
2026-08-01
Completion:
2033-01-01
Conditions
  • Lung Cancer
  • Non-small Cell Lung Cancer
  • Metastatic Lung Cancer
  • Head and Neck Cancer
  • Metastatic Squamous Cell Carcinoma
  • Metastatic Head and Neck Cancer
  • Resectable Head and Neck Squamous-cell Carcinoma
Interventions
  • DRUG
No Results Yet
NCT07607769 | RECRUITING
200 participants
NCT07552974 | NOT_YET_RECRUITING | PHASE2/PHASE3
100 participants

CBD Supplementation in Brazilian Jiu-Jitsu Athletes

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-27
Start Date:
2027-01-01
Completion:
2027-02-01
Conditions
  • Pro and Anti Inflamatory Cytokines
  • Pain
  • Sleep
  • Quality of Life
Interventions
  • DRUG
  • OTHER
No Results Yet
NCT07534332 | NOT_YET_RECRUITING | PHASE2
20 participants

Disulfiram in Rheumatoid Arthritis

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-27
Start Date:
2026-09-30
Completion:
2027-04-30
Conditions
  • Rheumatoid Arthritis
  • Inflammation
  • Obesity
Interventions
  • DRUG
No Results Yet
NCT07522099 | RECRUITING | PHASE2
30 participants

Chinese Adults With Kidney Disease

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-27
Start Date:
2026-05-21
Completion:
2028-07-10
Conditions
  • Immunoglobulin A Nephropathy (IgAN)
  • Complement 3 Glomerulopathy (C3G)
  • IC-MPGN
Interventions
  • DRUG
No Results Yet
NCT07491497 | RECRUITING | PHASE1/PHASE2
160 participants

A Phase 1/2 Study of TRI-611 in ALK-Positive NSCLC

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-27
Start Date:
2026-03-11
Completion:
2029-05-31
Conditions
  • ALK-positive NSCLC
  • ALK-Positive Lung Cancer
  • ALK-positive Non-small Cell Lung Cancer
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page